Application of Human Stem Cells to Model Genetic Sensorineural Hearing Loss and Meniere Disease

Cells. 2023 Mar 23;12(7):988. doi: 10.3390/cells12070988.

Abstract

Genetic sensorineural hearing loss and Meniere disease have been associated with rare variations in the coding and non-coding region of the human genome. Most of these variants were classified as likely pathogenic or variants of unknown significance and require functional validation in cellular or animal models. Given the difficulties to obtain human samples and the raising concerns about animal experimentation, human-induced pluripotent stem cells emerged as cellular models to investigate the interaction of genetic and environmental factors in the pathogenesis of inner ear disorders. The generation of human sensory epithelia and neuron-like cells carrying the variants of interest may facilitate a better understanding of their role during differentiation. These cellular models will allow us to explore new strategies for restoring hearing and vestibular sensory epithelia as well as neurons. This review summarized the use of human-induced pluripotent stem cells in sensorineural hearing loss and Meniere disease and proposed some strategies for its application in clinical practice.

Keywords: Meniere disease; biomedical applications; disease modeling; human-induced pluripotent stem cell; inner ear disorders; sensorineural hearing loss.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Differentiation / genetics
  • Hearing Loss, Sensorineural* / complications
  • Hearing Loss, Sensorineural* / genetics
  • Humans
  • Induced Pluripotent Stem Cells*
  • Meniere Disease* / genetics

Grants and funding

M.L. is funded by a research grant RH-0073-2021 from Andalusian Health Department. L.F. has received funds from Sara Borrell’s postdoctoral Fellowship (ISCIII; grant code: CD20/00153). A.G.-M. is funded by a postdoctoral grant from Economic Change, Industry, Knowledge and Universities Department (DOC_01677). J.A.L.-E. and L.F. also received funds for stem cell research from ibs.GRANADA (INTRAIBS-2021-07).